Found: 1
Select item for more details and to access through your institution.
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 6, p. 1379, doi. 10.1007/s40121-024-00981-8
- By:
- Publication type:
- Article